Ganymed Pharmaceuticals
Ganymed Pharmaceuticals is a biopharmaceutical developing therapeutic drugs designed to kill tumor cells without harming healthy tissues.
Business Model:
Revenue: $0
Employees: 11-50
Rankings
Industries / Tags:
Detailed Ganymed Pharmaceuticals Information
Ganymed Pharmaceuticals was acquired by
Astellas Pharma.
The acquisition happend on 2016-10-28.
Details of the transaction were not public
Acquirer
Geographic Data
Address:
City: Mainz
State: Rheinland-Pfalz
Zip:
Country: Germany
Financial Info
Stage:
series e
Raised Last:
$61M
Raised Total:$213M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Ganymed Pharmaceuticals AG is a biopharmaceutical company with the mission of revolutionizing cancer treatment by developing a new class of therapeutic drugs called Ideal Monoclonal Antibodies (IMABs). IMABs are unique in that they are highly selective for proteins which are present on tumor cells, but do not bind to healthy cells. This unmatched tumor cell specificity makes IMABs cancer cell selective allowing them to efficiently kill tumor cells without harming normal healthy tissues. They can thus be administered at optimal dose and have a broad therapeutic window with reduced risks of side effects.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 7/2005 | Series B | 3 | $14.4M |
Future Capital Landesbank Baden Wurttemberg Nextech Invest Future Capital Landesbank Baden Wurttemberg Nextech Invest |
11/2013 | Series E | $0 |
ATS Beteiligungsverwaltung FCPB Future Capital MIG ATS Beteiligungsverwaltung FCPB Future Capital MIG |
11/2008 | Series D | 3 | $81.8M |
ATS Beteiligungsverwaltung Future Capital MIG ATS Beteiligungsverwaltung Future Capital MIG |
6/2002 | Series A | 1 | $8.3M |
Nextech Invest Nextech Invest |
9/2007 | Series C | 5 | $47.5M |
ATS Beteiligungsverwaltung Future Capital Ingro Finanz AG Landesbank Baden Wurttemberg VI Partners ATS Beteiligungsverwaltung Future Capital Ingro Finanz AG Landesbank Baden Wurttemberg VI Partners |
11/2013 | Series E | 4 | $60.8M |
ATS Beteiligungsverwaltung FCPB Future Capital MIG ATS Beteiligungsverwaltung FCPB Future Capital MIG |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
